Frontiers in Oncology | Genitourinary Oncology

Case Report

Published on 08 Mar 2024

Case report: Exceptional and durable response to Radium-223 and suspension of androgen deprivation therapy in a metastatic castration-resistant prostate cancer patient

in Genitourinary Oncology

Francesca Zacchi
Joan Carles
Macarena Gonzalez
Xavier Maldonado
Raquel Perez-Lopez
Maria Eugenia Semidey
Joaquin Mateo

Frontiers in Oncology

doi 10.3389/fonc.2024.1331643

3,035 views
2 citations

Original Research

Published on 07 Mar 2024

SMMF: a self-attention-based multi-parametric MRI feature fusion framework for the diagnosis of bladder cancer grading

in Genitourinary Oncology

Tingting Tao
Ying Chen
Yunyun Shang
Jianfeng He
Jingang Hao

Frontiers in Oncology

doi 10.3389/fonc.2024.1337186

2,854 views
4 citations

Systematic Review

Published on 07 Mar 2024

A systematic review of primary large cell neuroendocrine carcinoma of the prostate

in Genitourinary Oncology

Ngan Nguyen
Ronald Dean Franz
Omar Mohammed
Richard Huynh
Christine Kim Son
Rida Nusrat Khan
Bilawal Ahmed

Frontiers in Oncology

doi 10.3389/fonc.2024.1341794

5,172 views
12 citations

Original Research

Published on 06 Mar 2024

Imaging classification of prostate cancer with extracapsular extension and its impact on positive surgical margins after laparoscopic radical prostatectomy

in Genitourinary Oncology

Jun-Guang Wang
Chao Zhong
Ke-Cheng Zhang
Jun-Bo Chen

Frontiers in Oncology

doi 10.3389/fonc.2024.1344050

2,161 views
3 citations

Original Research

Published on 05 Mar 2024

Prostate cancer risk stratification via eNose urine odor analysis: a preliminary report

in Genitourinary Oncology

Gianluigi Taverna
Fabio Grizzi
Carmen Bax
Lorenzo Tidu
Matteo Zanoni
Paolo Vota
Cinzia Mazzieri
Maria Chiara Clementi
Giovanni Toia
Mohamed A. A. A. Hegazi

Frontiers in Oncology

doi 10.3389/fonc.2024.1339796

2,629 views
2 citations

Correction

Published on 01 Mar 2024

Corrigendum: Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms

in Genitourinary Oncology

Viktor Grünwald
Thomas Powles
Masatoshi Eto
Evgeny Kopyltsov
Sun Young Rha
Camillo Porta
Robert Motzer
Thomas E. Hutson
María José Méndez-Vidal
Sung-Hoo Hong

Frontiers in Oncology

doi 10.3389/fonc.2023.1343027

3,792 views
6 citations

Original Research

Published on 01 Mar 2024

DNA damage levels in peripheral blood mononuclear cells before and after first cycle of chemotherapy have comparable prognostic values in germ cell tumor patients

in Genitourinary Oncology

Danica Ivovič
Zuzana Šestáková
Jan Roška
Katarína Kálavská
Lenka Hurbanová
Andrea Holíčková
Božena Smolková
Pavlína Kabelíková
Věra Novotná
Michal Chovanec

Frontiers in Oncology

doi 10.3389/fonc.2024.1360678

2,530 views

Editorial

Published on 01 Mar 2024

Editorial: Liquid biopsy in the detection and prediction of outcomes in bladder cancer

in Genitourinary Oncology

Nicola Pavan
Bruna Scaggiante

Frontiers in Oncology

doi 10.3389/fonc.2024.1391466

1,738 views
1 citation

Case Report

Published on 01 Mar 2024

Case report and literature review: plexiform schwannoma in the penile and inguinal region in a child

in Genitourinary Oncology

Xiaoying Qi
Yifei Tan
Yanru Feng
Dan Ma
Ling Wang
Houqing Pang

Frontiers in Oncology

doi 10.3389/fonc.2024.1356000

3,114 views
2 citations

Case Report

Published on 01 Mar 2024

Acute urinary retention due to corpus cavernosum penile metastasis from lung adenocarcinoma after targeted therapy: a case report and review of the literature

in Genitourinary Oncology

Wei Yan
Hui Fu
Huiqun Liu
Zhentian Liu
Xueliang Qi
Tanxiu Chen

Frontiers in Oncology

doi 10.3389/fonc.2024.1278245

2,395 views
2 citations

Review

Published on 01 Mar 2024

A narrative review on the application of artificial intelligence in renal ultrasound

in Genitourinary Oncology

Tong Xu
Xian-Ya Zhang
Na Yang
Fan Jiang
Gong-Quan Chen
Xiao-Fang Pan
Yue-Xiang Peng
Xin-Wu Cui

Frontiers in Oncology

doi 10.3389/fonc.2023.1252630

5,727 views
5 citations

Original Research

Published on 29 Feb 2024

Identification of FLRT2 as a key prognostic gene through a comprehensive analysis of TMB and IRGPs in BLCA patients

in Genitourinary Oncology

Yaling Tao
Xiaoling Yu
Huaiwei Cong
Jinpeng Li
Junqi Zhu
Huaxin Ding
Qian Chen
Ting Cai

Frontiers in Oncology

doi 10.3389/fonc.2023.1229227

2,961 views
3 citations

Original Research

Published on 28 Feb 2024

Prediction of Ki-67 expression in bladder cancer based on CT radiomics nomogram

in Genitourinary Oncology

Shengxing Feng
Dongsheng Zhou
Yueming Li
Runqiang Yuan
Jie Kong
Feng Jiang
Weitian Chen
Lijie Zhang
Mancheng Gong

Frontiers in Oncology

doi 10.3389/fonc.2024.1276526

2,665 views
6 citations

Case Report

Published on 28 Feb 2024

Case report: A collision tumor of clear cell renal cell carcinoma and clear cell papillary renal cell tumor

in Genitourinary Oncology

Yingsheng Lin
Jinan Guo
Zaishang Li
Zengqin Liu
Jing Xie
Junxu Liu
Hongtao Jin
Kefeng Xiao

Frontiers in Oncology

doi 10.3389/fonc.2024.1284194

2,335 views
1 citation

Original Research

Published on 27 Feb 2024

Serum EZH2 is a novel biomarker for bladder cancer diagnosis and prognosis

in Genitourinary Oncology

Feng Li
Pengqiao Wang
Jun Ye
Guoping Xie
Jinfeng Yang
Wei Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1303918

2,634 views
7 citations

Original Research

Published on 27 Feb 2024

Deep learning-based radiomics model from pretreatment ADC to predict biochemical recurrence in advanced prostate cancer

in Genitourinary Oncology

Huihui Wang
Kexin Wang
Yaofeng Zhang
Yuke Chen
Xiaodong Zhang
Xiaoying Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1342104

2,651 views
10 citations

Original Research

Published on 26 Feb 2024

Predictive value of volumetric parameters based on 18F-PSMA-1007 PET/CT for prostate cancer metastasis

in Genitourinary Oncology

Yanmei Li
Jian Chen
Xiaojuan Wang
Pengfei Yang
Jiqin Yang
Qian Zhao
Juan Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1335205

2,159 views
3 citations

Original Research

Published on 21 Feb 2024

BioPrev-C – development and validation of a contemporary prostate cancer risk calculator

in Genitourinary Oncology

Thomas Hermanns
Marian S. Wettstein
Basil Kaufmann
Noémie Lautenbach
Ernest Kaufmann
Karim Saba
Florian A. Schmid
Andreas M. Hötker
Michael Müntener
Martin Umbehr

Frontiers in Oncology

doi 10.3389/fonc.2024.1343999

1,589 views
1 citation

Original Research

Published on 21 Feb 2024

Genomic amplifications identified by circulating tumor DNA analysis guide prognosis in metastatic castration-resistant prostate cancer

in Genitourinary Oncology

Toros A. Dincman
Joseph A. Q. Karam
Antonio Giordano
Hong Li
Leylah M. Drusbosky
Theodore S. Gourdin
Philip H. Howe
Michael B. Lilly

Frontiers in Oncology

doi 10.3389/fonc.2023.1202277

3,047 views
1 citation

Original Research

Published on 21 Feb 2024

Predictive value of controlling nutritional status score for prostate cancer diagnosis

in Genitourinary Oncology

Jiaguo Huang
Ji Sun
Runmiao Hua
Yi Fan
Kai Wang
Liying Zheng
Biao Qian

Frontiers in Oncology

doi 10.3389/fonc.2024.1268800

1,726 views

Original Research

Published on 20 Feb 2024

Lower baseline testosterone level is related to earlier development of castration resistance in metastatic prostate cancer: a multi-center cohort study

in Genitourinary Oncology

Ho Ming Chris Wong
Peter Ka-Fung Chiu
Ignacio Puche-Sanz
Zhao Xue
Dong-Ning Chen
Enrique Gomez-Gomez
Isabel Heidegger
Mona Kafka
Yong Wei
Shinichi Sakamoto

Frontiers in Oncology

doi 10.3389/fonc.2024.1321522

2,516 views
3 citations

Original Research

Published on 15 Feb 2024

Absence of GATA3/FOXA1 co-expression predicts poor prognosis in upper tract urothelial carcinoma

in Genitourinary Oncology

Yue Wang
Yunfan Wang
Huiying He
Yan Xiong

Frontiers in Oncology

doi 10.3389/fonc.2024.1302864

2,142 views

Case Report

Published on 15 Feb 2024

Case report: Enfortumab vedotin induced refractory DKA and multi organ failure – a rare fatal adverse event

in Genitourinary Oncology

Astha Koolwal Kapoor
Carleton S. Ellis
Deepali Pandey
Derek B. Allison
Zin W. Myint

Frontiers in Oncology

doi 10.3389/fonc.2024.1332478

3,585 views
9 citations

Original Research

Published on 12 Feb 2024

Time to strategy failure and treatment beyond progression in pretreated metastatic renal cell carcinoma patients receiving nivolumab: post-hoc analysis of the Meet-URO 15 study

in Genitourinary Oncology

Veronica Murianni
Alessio Signori
Sebastiano Buti
Sara Elena Rebuzzi
Davide Bimbatti
Ugo De Giorgi
Silvia Chiellino
Luca Galli
Paolo Andrea Zucali
Cristina Masini

Frontiers in Oncology

doi 10.3389/fonc.2024.1307635

2,641 views
3 citations

1,822 articles

articles

Case report: Exceptional and durable response to Radium-223 and suspension of androgen deprivation therapy in a metastatic castration-resistant prostate cancer patient

SMMF: a self-attention-based multi-parametric MRI feature fusion framework for the diagnosis of bladder cancer grading

A systematic review of primary large cell neuroendocrine carcinoma of the prostate

Imaging classification of prostate cancer with extracapsular extension and its impact on positive surgical margins after laparoscopic radical prostatectomy

Prostate cancer risk stratification via eNose urine odor analysis: a preliminary report

Corrigendum: Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms

DNA damage levels in peripheral blood mononuclear cells before and after first cycle of chemotherapy have comparable prognostic values in germ cell tumor patients

Editorial: Liquid biopsy in the detection and prediction of outcomes in bladder cancer

Case report and literature review: plexiform schwannoma in the penile and inguinal region in a child

Acute urinary retention due to corpus cavernosum penile metastasis from lung adenocarcinoma after targeted therapy: a case report and review of the literature

A narrative review on the application of artificial intelligence in renal ultrasound

Identification of FLRT2 as a key prognostic gene through a comprehensive analysis of TMB and IRGPs in BLCA patients

Prediction of Ki-67 expression in bladder cancer based on CT radiomics nomogram

Case report: A collision tumor of clear cell renal cell carcinoma and clear cell papillary renal cell tumor

Serum EZH2 is a novel biomarker for bladder cancer diagnosis and prognosis

Deep learning-based radiomics model from pretreatment ADC to predict biochemical recurrence in advanced prostate cancer

Predictive value of volumetric parameters based on 18F-PSMA-1007 PET/CT for prostate cancer metastasis

BioPrev-C – development and validation of a contemporary prostate cancer risk calculator

Genomic amplifications identified by circulating tumor DNA analysis guide prognosis in metastatic castration-resistant prostate cancer

Predictive value of controlling nutritional status score for prostate cancer diagnosis

Lower baseline testosterone level is related to earlier development of castration resistance in metastatic prostate cancer: a multi-center cohort study

Absence of GATA3/FOXA1 co-expression predicts poor prognosis in upper tract urothelial carcinoma

Case report: Enfortumab vedotin induced refractory DKA and multi organ failure – a rare fatal adverse event

Time to strategy failure and treatment beyond progression in pretreated metastatic renal cell carcinoma patients receiving nivolumab: post-hoc analysis of the Meet-URO 15 study